Corient Private Wealth LP bought a new stake in shares of Cigna Group (NYSE:CI – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 554,756 shares of the health services provider’s stock, valued at approximately $40,315,000.
Several other hedge funds and other institutional investors also recently modified their holdings of CI. Evercore Wealth Management LLC boosted its position in Cigna Group by 2.8% during the 1st quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock valued at $347,000 after acquiring an additional 35 shares in the last quarter. Cary Street Partners Investment Advisory LLC boosted its holdings in Cigna Group by 11.0% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock worth $100,000 after acquiring an additional 36 shares in the last quarter. IHT Wealth Management LLC raised its position in shares of Cigna Group by 2.5% in the 4th quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider’s stock worth $423,000 after purchasing an additional 38 shares during the last quarter. Whetstone Capital Advisors LLC boosted its stake in Cigna Group by 4.9% in the 4th quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider’s stock worth $228,000 after purchasing an additional 39 shares in the last quarter. Finally, CYBER HORNET ETFs LLC grew its position in Cigna Group by 5.3% during the 4th quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock valued at $220,000 after purchasing an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Insider Transactions at Cigna Group
In other news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 23,012 shares of company stock valued at $6,386,550. Company insiders own 0.60% of the company’s stock.
Cigna Group Trading Down 1.3%
Cigna Group (NYSE:CI – Get Free Report) last released its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the previous year, the firm earned $7.20 earnings per share. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, analysts predict that Cigna Group will post 30.51 EPS for the current fiscal year.
Cigna Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is 25.82%.
Analysts Set New Price Targets
CI has been the subject of a number of analyst reports. Barclays raised their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Guggenheim increased their price target on shares of Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a report on Friday, July 31st. Sanford C. Bernstein boosted their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Mizuho upped their price objective on Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Finally, Cantor Fitzgerald lifted their target price on Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $339.45.
View Our Latest Stock Report on Cigna Group
Cigna Group Company Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Further Reading
- Five stocks we like better than Cigna Group
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
